1. Home
  2. Our Services
  3. Securities
  4. Recent Transactions

 

Announcement Type Status Transaction Value
Oct 2019 Financing Closed Lead manager to Viela Bio on its initial public offering $173 million
Oct 2019 Advisory Pending Financial advisor to Mednax in connection with its sale of MedData to Frazier Healthcare Partners. $250mm, plus up to $50mm of Potential Earn Outs
Sep 2019 Financing Closed Co-manager to SJI on its junior subordinated notes $200 million
Sep 2019 Financing Closed Joint bookrunner to IGM Biosciences,Inc. on its initial public offering $201 million
Sep 2019 Financing Closed Joint bookrunner to Bellus Health on its U.S. initial public offering $79 million
Sep 2019 Financing Closed Co-manager to SmileDirectClub on its initial public offering $1.3 billion
Aug 2019 Advisory Pending Financial advisor to Thomson Reuters in connection with the all-stock sale of Refinitiv to the London Stock Exchange $27 billion
Aug 2019 Advisory Pending Financial advisor to Sinclair Broadcast Group Inc. in its participation in a newly formed investor group that is acquiring The Walt Disney Company’s equity interest in the Yes Network $2.8 billion
Aug 2019 Advisory Closed Exclusive Financial advisor to Altas Partners in connection with its acquisition of DuBois Chemicals Undisclosed
Jul 2019 Advisory Pending Financial advisor to Pfizer in connection with its separation of Up John and combination with Mylan Combined enterprise value of ~$47 billion


© 2019 Guggenheim Partners, LLC. All rights reserved. Guggenheim, Guggenheim Partners and Innovative Solutions. Enduring Values. are registered trademarks of Guggenheim Capital, LLC.